Form D · Biotechnology

ArunA Bio, Inc.

Athens, GA · CIK 0001447734

Offering snapshot reported Aug 1, 2019 · SEC filing

Reported sold
$13.3M
Offering amount: $13.3M
Investors reported
81
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 19, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 1, 2019Initial$13,292,000No comparison81SEC filing
Jul 19, 2018Initial$5,380,504No comparison32SEC filing
Apr 28, 2017Amendment$3,735,000$2,575,000vs Aug 24, 201614SEC filing
Aug 24, 2016Initial$1,160,000No comparison6SEC filing
Oct 8, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-345603

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANone

Source: Form D, filed Aug 1, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Darren Devore Director
Darren De Vore Director
C. William Griffin Director
C. William Griffin Director
Harold Ingalls Director
Mason Irving Director
Mason Irving, Iii Director
Russell Lindner Director
John Mangan Director
John Mangan, Jr. Director
Al Medwar Executive
Mark Sirgo Director, Executive
Tracey Stice Executive
Steven Stice Director, Executive
Barry Storey Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
425 River Road
Athens, GA, 30602